methylprednisolone has been researched along with Brain Vascular Disorders in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Aajal, A; Ait Brik, A; Ammour, O; Benajiba, C; El Boussadani, B; El Hangouch, J; Oussama, B; Oussama, O; Raissuni, Z; Tahiri, N | 1 |
| Alves, JN; Carvalho, R; Dias, L; Marques, S; Matos, AR; Oliveira, AI; Quintas-Neves, M | 1 |
| Ikeda, K; Iwamoto, K; Iwasaki, Y; Mizumura, S; Tachiki, K; Yanagihashi, M | 1 |
| Sun, Z; Wang, J; Wang, K; Zhuo, S | 1 |
| Kantarci, OH; Lennon, VA; Lucchinetti, CF; Magaña, SM; Matiello, M; McKeon, A; Pittock, SJ; Rabinstein, AA; Shuster, E; Weinshenker, BG | 1 |
| Bleck, TP; Fletcher, JJ; Kramer, AH; Solenski, NJ | 1 |
| Al-Mayouf, SM; Muzaffer, MA; Olfat, MO | 1 |
| Basilli, S; Donnan, GA; Plummer, C; Rattray, K | 1 |
| Matsumoto, A; Tajima, Y | 1 |
| Li, Q; Qin, X; Xie, P | 1 |
| Brunner, K; Goldhirsch, A; Joss, R; Markwalder, TM; Studer, H | 1 |
| Pomeranz, S; Safar, P | 1 |
| de Courten-Myers, GM; Kleinholz, M; Myers, RE; Wagner, KR; Xi, G | 1 |
| Caselli, RJ; Hunder, GG | 1 |
| Blanco, R; Delgado-Rodriguez, M; Figueroa, M; González-Gay, MA; Martínez-Taboada, VM; Rodríguez-Valverde, V; Uriarte, E | 1 |
| Bakkaloğlu, SA; Deda, G; Ekim, M; Erdem, T; Erden, I; Tümer, N | 1 |
| Emerson, TE; Raymond, RM | 1 |
| Hall, ED | 1 |
| Bassaris, HP; Kyriazopoulou, VE; Lianou, PE; Mallioris, KN; Papavassiliou, JT; Skoutelis, AT; Votta, EG | 1 |
| Braughler, JM; Lainer, MJ | 1 |
| Allegre, G; Bouvier, C; Dechaume, JP; Porta, JP; Thierry, A | 1 |
3 review(s) available for methylprednisolone and Brain Vascular Disorders
| Article | Year |
|---|---|
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1
Topics: Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiomyopathies; Cardiovascular Diseases; Cerebrovascular Disorders; Chloroquine; Comorbidity; Coronary Disease; Coronavirus Infections; COVID-19; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Virus Internalization | 2020 |
Giant cell (temporal) arteritis.
Topics: Adrenal Cortex Hormones; Cerebrovascular Disorders; Cranial Nerve Diseases; Giant Cell Arteritis; Humans; Methylprednisolone; Prednisone; Prognosis | 1997 |
The neuroprotective pharmacology of methylprednisolone.
Topics: Animals; Brain Injuries; Cerebrovascular Disorders; Humans; Methylprednisolone; Spinal Cord Injuries | 1992 |
18 other study(ies) available for methylprednisolone and Brain Vascular Disorders
| Article | Year |
|---|---|
COVID-19 Associated Central Nervous System Vasculopathy.
Topics: Adult; Angiography, Digital Subtraction; Basal Ganglia; Cerebral Angiography; Cerebrovascular Disorders; Cognitive Dysfunction; COVID-19; COVID-19 Drug Treatment; Deglutition Disorders; Diffusion Magnetic Resonance Imaging; Dysphonia; Emergency Service, Hospital; Executive Function; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Patient Discharge; Pons; Posterior Cerebral Artery; SARS-CoV-2; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed; White Matter | 2021 |
Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report.
Topics: Antiparkinson Agents; Carbon Monoxide Poisoning; Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Therapy, Combination; Glucocorticoids; Humans; Hyperbaric Oxygenation; Male; Memantine; Methylprednisolone; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease, Secondary; Perfusion Imaging; Pulse Therapy, Drug; Recovery of Function; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Sigmoid sinus occlusion infiltrated by inflammatory myofibroblastic tumor from mastoid.
Topics: Adult; Bone Diseases; Cerebrovascular Disorders; Cranial Sinuses; Glucocorticoids; Granuloma, Plasma Cell; Humans; Immunoglobulin G; Intracranial Hypertension; Male; Mastoid; Methylprednisolone | 2015 |
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
Topics: Adolescent; Adult; Antibodies; Aquaporin 4; Autoimmunity; Body Water; Brain; Brain Edema; Cerebrovascular Disorders; Child; Comorbidity; Confusion; Consciousness Disorders; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Remission, Spontaneous; Syndrome; Time Factors; Young Adult | 2009 |
Overlapping features of eclampsia and postpartum angiopathy.
Topics: Adult; Cerebrovascular Disorders; Eclampsia; Female; Headache; Humans; Methylprednisolone; Nicardipine; Postpartum Period; Pregnancy; Puerperal Disorders; Retrospective Studies; Seizures; Stroke; Subarachnoid Hemorrhage; Vasoconstriction; Vasodilator Agents; Verapamil; Young Adult | 2009 |
Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.
Topics: Adolescent; Cerebrovascular Disorders; Child; Child, Preschool; Disease-Free Survival; Electroencephalography; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Male; Methylprednisolone; Nervous System Diseases; Prednisone; Treatment Outcome | 2004 |
An unusual disease presenting at an unusual age: Susac's syndrome.
Topics: Anti-Inflammatory Agents; Anticoagulants; Cerebral Angiography; Cerebrovascular Disorders; Cochlear Diseases; Cognition Disorders; Female; Hearing Disorders; Humans; Methylprednisolone; Middle Aged; Retinal Diseases; Syndrome; Warfarin | 2005 |
Reversible posterior leukoencephalopathy syndrome in p-ANCA-associated vasculitis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cardiomyopathies; Cerebrovascular Disorders; Diplopia; Edema; Fatal Outcome; Female; Fever; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Organ Failure; Rheumatoid Factor; Ultrasonography; Vasculitis; Vasodilation | 2006 |
Susac's syndrome presenting with consciousness disturbance.
Topics: Adult; Angiography; Anti-Inflammatory Agents; Audiometry; Autoimmune Diseases of the Nervous System; Cerebrovascular Disorders; Consciousness Disorders; Diagnosis, Differential; Female; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Methylprednisolone; Retinal Diseases; Syndrome | 2008 |
Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebrovascular Disorders; Cisplatin; Female; Humans; Methylprednisolone; Middle Aged; Ovarian Neoplasms | 1983 |
Experimental stroke treatment with high-dose methylprednisolone.
Topics: Cerebrovascular Disorders; Humans; Methylprednisolone | 1994 |
Efficacious experimental stroke treatment with high-dose methylprednisolone.
Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Brain Edema; Carbon Dioxide; Cats; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Drug Administration Schedule; Heart Rate; Infusions, Intravenous; Methylprednisolone; Oxygen; Random Allocation; Regional Blood Flow; Time Factors | 1994 |
Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Cerebrovascular Disorders; Female; Forecasting; Giant Cell Arteritis; Humans; Injections, Intravenous; Male; Methylprednisolone; Prednisone; Regression Analysis; Retrospective Studies; Vision Disorders | 1998 |
Cerebral vasculitis in Henoch-Schönlein purpura.
Topics: Anti-Inflammatory Agents; Cerebrovascular Disorders; Child; Humans; IgA Vasculitis; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone | 2000 |
Methylprednisolone in the prevention of cerebral hemodynamic and metabolic disorders during endotoxin shock in the dog.
Topics: Animals; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Dogs; Escherichia coli; Female; Glucose; Hemodynamics; Male; Methylprednisolone; Shock, Septic | 1979 |
Effects of methylprednisolone and dexamethasone on polymorphonuclear leukocyte adherence in vivo.
Topics: Cell Adhesion; Cerebrovascular Disorders; Dexamethasone; Humans; Methylprednisolone; Neutrophils; Shock, Septic | 1987 |
The effects of large doses of methylprednisolone on neurologic recovery and survival in the Mongolian gerbil following three hours of unilateral carotid occlusion.
Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Injections, Intraperitoneal; Ischemic Attack, Transient; Male; Methylprednisolone; Time Factors | 1986 |
[Use of sodium methyl-6-prednisolone hemisuccinate (Solumedrol) in the treatment of intracranial hypertension and various severe neurologic states].
Topics: Brain Diseases; Brain Edema; Brain Injuries; Brain Neoplasms; Cerebrovascular Disorders; Humans; Intracranial Pressure; Methylprednisolone; Succinates | 1971 |